Catalyst Wire Dossier Catalyst Wire Dossier

Luvadaxistat

luvadaxistat · Neurocrine Biosciences
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Luvadaxistat, covering 2024-02-28 to 2025-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia [Phase 2]

See pricing